Three year survival among patients with aids-related Kaposi sarcoma treated with chemotherapy and combination antiretroviral therapy at Moi teaching and referral hospital, Kenya

Table 2 Hazard Ratios of identified determinants of 3-year survival

	Unadjusted HR (95% CI)	Unadj. p-value	Adjusted HR (95% CI)	Adj. p-value
Response after 6 weeks	0.961(0.208,4.45)	0.96	1.212(0.257,5.716)	0.808
Age at Enrollment (per 1-year increase)	0.944(0.867,1.027)	0.182	0.937(0.86,1.021)	0.136
Male gender	1.018(0.311,3.338)	0.976	1.294(0.387,4.332)	0.676
Initial CD4 = > 500/μl	0.483(0.062,3.777)	0.488	0.401(0.05,3.23)	0.391

Adjusted HR refers to adjustment for the other 3 determinants e.g. adjusted HR for Response after 6 weeks refers to the HR after adjusting for age, gender and initial CD4 cell count

ISSN: 1750-9378